CONSOLIDATED BALANCE SHEETS - USD ($)	Jul. 31, 2017	Jul. 31, 2016
Current Assets:
Cash and cash equivalents	$ 2,879,165	$ 16,899
Inventory, net	10,035
Other current assets	21,891	8,077
Total Current Assets	2,911,091	24,976
Property and equipment (Note 3)	573	1,298
Call option (Note 14)	4,237,829
Intangible asset (Note 14)	2,911,377
Patents, net (Note 4)	25,851
Other assets, net	7,824
TOTAL ASSETS	10,094,545	26,274
Current Liabilities:
Accounts payable and accrued expenses	10,172,610	8,950,870
Loans from related parties (Note 6)	13,738,140
Loan payable (Note 7)		50,000
Total Current Liabilities	23,910,750	9,000,870
Derivative warrant liability (Note 11 and 12)		2,048,846
Derivative additional investment rights liability (Note 11 and 12 and 14)		193,408
Warrants to be issued (Note 14)	66,060,026
Total Liabilities	89,970,776	11,243,124
Stockholders' Deficiency (Note 11):
Common stock, $.001 par value; authorized 2,450,000 and 2,450,000 shares at July 31, 2017 and July 31, 2016, respectively; 1,068,101 and 908,541 issued and outstanding at July 31, 2017 and July 31, 2016, respectively	1,068	909
Common stock payable	2,168,951
Additional paid-in capital	368,409,627	363,687,741
Accumulated deficit	(445,720,566)	(375,704,372)
Accumulated other comprehensive income	783,150	798,872
Non-controlling interest	(5,518,465)
Total Stockholders' Deficiency	(79,876,231)	(11,216,850)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIENCY	10,094,545	26,274
Series F Convertible Preferred Stock
Stockholders' Deficiency (Note 11):
9% Convertible Preferred Stock
Series G Convertible Preferred Stock
Stockholders' Deficiency (Note 11):
9% Convertible Preferred Stock
Series H Convertible Preferred Stock
Stockholders' Deficiency (Note 11):
9% Convertible Preferred Stock	3
Series I Convertible Preferred Stock
Stockholders' Deficiency (Note 11):
9% Convertible Preferred Stock	$ 1